This procedure may represent a potential treatment option for individuals diagnosed with keratoconus and corneal ectasia after refractive surgery.Omaha, NE (PRWEB) December 22, 2012 On November 7, 2012 , Kugler Vision became one of the first institutio…
Intercept Completes Enrollment In Phase 3 Primary Biliary Cirrhosis POISE Trial
NEW YORK — Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver …
The old Bee Gees song “Stayin’ Alive” could be the mantra for three members of a Leominster family who have been helped by three generations of ventricular assist devices.
Beijing (China Daily/ANN) – China is set to expand a computerised system to ensure transparent and fair allocation of donor organs, according to Vice-Minister of Health Huang Jiefu.
ANKENY, Iowa (AP) — A trial date has been set for a suburban Des Moines couple accused of keeping two teenage children locked in the basement when not at school.
SAN DIEGO, Dec. 11, 2012 /PRNewswire/ — Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today …
Ligand Pharmaceuticals Incorporated announced today that it has initiated a pivotal trial of Captisol-enabled, propylene glycol-free (PG-free) high-dose melphalan as a conditioning treatment prior to autologous transplant for patients with multiple mye…
Ligand Pharmaceuticals Incorporated announced today that it has initiated a pivotal trial of Captisol-enabled®, propylene glycol-free high-dose melphalan as a conditioning treatment prior to autologous transplant for patients with multiple myeloma.
A new study shows that preparing older acute myeloid leukemia patients for bone marrow transplants with a reduced intensity conditioning regimen appears to be associated with higher rates of disease-free survival relative to the more typical treatments…